+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver Cirrhosis Treatment Market Segments by Treatment Type, by End-user, and by Region

  • PDF Icon

    Report

  • 200 Pages
  • October 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 6008263
The global liver cirrhosis treatment market accounted for USD 7.17 billion in 2023 and is expected to reach at USD 22.43 billion by 2034 with a CAGR of 10.93% during the forecast period 2024-2034. The market will grow as a result of factors such as the increasing prevalence of liver cirrhosis, technological advancements in medicine, increased awareness and screening initiatives, rising demand for liver transplants, and smart alliances and coordination.

Numerous conditions, including alcohol misuse, viral hepatitis (including hepatitis B and C), non-alcoholic fatty liver disease (NAFLD), and autoimmune liver illnesses, can induce liver cirrhosis, which is a major global health burden. The demand for therapeutic alternatives is fueled by the rising frequency and prevalence of these underlying diseases, which also increase the prevalence of liver cirrhosis. For instance, in May 2023, Gilead Sciences, Inc. reported favorable outcomes from a Phase 3 trial assessing filgotinib as a possible treatment for cirrhosis caused by non-alcoholic steatohepatitis (NASH).

By treatment type, the antiviral drugs segment accounted for the highest revenue-grossing segment in the global liver cirrhosis treatment market in 2023 owing to the high prevalence of viral hepatitis, particularly hepatitis C, a major cause of cirrhosis. For instance, in April 2024, AbbVie Inc. received FDA clearance for Skyrizi (risankizumab-rzaa), a medication used to treat individuals with moderate to severe active Crohn's disease, which can occasionally result in cirrhosis. Additionally, the target therapy segment is predicted to grow at the fastest CAGR during the forecast period owing to the development of new, more specific drugs that target the underlying mechanisms of cirrhosis progression.

By end-user, the hospitals segment accounted for the highest revenue-grossing segment in the global liver cirrhosis treatment market in 2023 owing to the complex nature of liver cirrhosis treatment, which often requires hospitalization for procedures or close monitoring. For instance, in February 2024, the Bristol-Myers Squibb Company presented data at a medical conference showcasing the potential of Yervoy (ipilimumab) in conjunction with Opdivo (nivolumab) for the treatment of hepatocellular carcinoma (HCC), a kind of liver cancer that can arise from cirrhosis. Additionally, the ambulatory surgical centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing adoption of minimally invasive procedures for liver cirrhosis treatment.

North American region is anticipated to have the highest revenue share during the forecast period owing to the well-developed healthcare infrastructure, high prevalence of liver diseases, and strong government support for research and development. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising prevalence of hepatitis B, increasing disposable income, and growing awareness of liver diseases. For instance, in December 2023, Merck & Co., Inc. announced that it was partnering with a biotechnology company to create new treatments that specifically target pathways linked to liver fibrosis, a defining feature of the evolution of cirrhosis.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Treatment Type, and End-User
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement

Segmentation: Liver Cirrhosis Treatment Market Report 2023 - 2034

Liver Cirrhosis Treatment Market Analysis & Forecast by Treatment Type 2023 - 2034 (Revenue USD Bn)

  • Antiviral Drugs
  • Immunosuppressants
  • Vaccines
  • Immunoglobulins
  • Target Therapy
  • Others

Liver Cirrhosis Treatment Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Liver Cirrhosis Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Liver Cirrhosis Treatment Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.1.1. Rising Incidence of Traumatic Injuries and Surgeries
5.1.2. Advancements in Hemostatic Technologies
5.1.3. Increasing Adoption of Minimally Invasive Surgeries
5.1.4. Rising Healthcare Expenditure and Infrastructure Development
5.2. Restraints Analysis
5.2.1. High Cost of Advanced Hemostatic Dressings
5.2.2. Stringent Regulatory Approval Processes
5.2.3. Potential Adverse Reactions and Complications
5.3. Opportunities Analysis
5.3.1. Expansion in Emerging Markets
5.3.2. Development of Customized and Specialized Products
5.3.3. Collaborations and Partnerships
5.4. Threats Analysis
5.4.1. Intense Competition and Price Pressures
5.4.2. Regulatory and Reimbursement Challenges
5.4.3. Emergence of Alternative Hemostatic Solutions
5.5. Trend Analysis
5.5.1. Shift Towards Biodegradable and Bioresorbable Materials
5.5.2. Focus on Antimicrobial and Antifungal Properties
5.5.3. Personalized and Precision Medicine Approaches
6. COVID-19 Impact Analysis
7. Liver Cirrhosis Treatment Market: Treatment Type Estimates & Trend Analysis
7.1. Treatment Type Segment Opportunity Analysis
7.2. Antiviral Drugs
7.2.1. Antiviral Drugs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Immunosuppressants
7.3.1. Immunosuppressants Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Vaccines
7.4.1. Vaccines Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Immunoglobulins
7.5.1. Immunoglobulins Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Target Therapy
7.6.1. Target Therapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.7. Others
7.7.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Liver Cirrhosis Treatment Market: End-User Estimates & Trend Analysis
8.1. End-User Segment Opportunity Analysis
8.2. Hospitals
8.2.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Specialty Clinics
8.3.1. Specialty Clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Ambulatory Surgical Centers
8.4.1. Ambulatory Surgical Centers Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Regional Market Analysis
9.1. Regional Market Opportunity Analysis
10. North America Liver Cirrhosis Treatment Market
10.1. North America Liver Cirrhosis Treatment Market
10.1.1. North America Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.1.2. North America Liver Cirrhosis Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
10.1.3. North America Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
10.1.4. North America Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
10.2. U.S. Global Liver Cirrhosis Treatment Market
10.2.1. U.S. Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.2.2. U.S. Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
10.2.3. U.S. Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
10.3. Canada Global Liver Cirrhosis Treatment Market
10.3.1. Canada Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.3.2. Canada Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
10.3.3. Canada Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11. Europe Global Liver Cirrhosis Treatment Market
11.1. Europe Global Liver Cirrhosis Treatment Market
11.1.1. Europe Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. Europe Liver Cirrhosis Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. Europe Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
11.1.4. Europe Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.2. Germany Global Liver Cirrhosis Treatment Market
11.2.1. Germany Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. Germany Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
11.2.3. Germany Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.3. UK Global Liver Cirrhosis Treatment Market
11.3.1. UK Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. UK Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
11.3.3. UK Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.4. France Global Liver Cirrhosis Treatment Market
11.4.1. France Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.4.2. France Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
11.4.3. France Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.5. Spain Global Liver Cirrhosis Treatment Market
11.5.1. Spain Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.5.2. Spain Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
11.5.3. Spain Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.6. Italy Global Liver Cirrhosis Treatment Market
11.6.1. Italy Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.6.2. Italy Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
11.6.3. Italy Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.7. Rest of Europe Global Liver Cirrhosis Treatment Market
11.7.1. Rest of Europe Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.7.2. Rest of Europe Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
11.7.3. Rest of Europe Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12. Asia Pacific Global Liver Cirrhosis Treatment Market
12.1. Asia Pacific Global Liver Cirrhosis Treatment Market
12.1.1. Asia Pacific Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Asia Pacific Liver Cirrhosis Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Asia Pacific Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
12.1.4. Asia Pacific Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.2. Japan Global Liver Cirrhosis Treatment Market
12.2.1. Japan Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Japan Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
12.2.3. Japan Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.3. China Global Liver Cirrhosis Treatment Market
12.3.1. China Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. China Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
12.3.3. China Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.4. India Global Liver Cirrhosis Treatment Market
12.4.1. India Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. India Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
12.4.3. India Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.5. South Korea Global Liver Cirrhosis Treatment Market
12.5.1. South Korea Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. South Korea Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
12.5.3. South Korea Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.6. Australia Global Liver Cirrhosis Treatment Market
12.6.1. Australia Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Australia Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
12.6.3. Australia Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.7. Rest of Asia Pacific Global Liver Cirrhosis Treatment Market
12.7.1. Rest of Asia Pacific Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Asia Pacific Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Asia Pacific Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13. Latin America Global Liver Cirrhosis Treatment Market
13.1. Latin America Global Liver Cirrhosis Treatment Market
13.1.1. Latin America Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Latin America Liver Cirrhosis Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Latin America Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
13.1.4. Latin America Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.2. Brazil Global Liver Cirrhosis Treatment Market
13.2.1. Brazil Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Brazil Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
13.2.3. Brazil Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.3. Mexico Global Liver Cirrhosis Treatment Market
13.3.1. Mexico Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. Mexico Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
13.3.3. Mexico Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.4. Argentina Global Liver Cirrhosis Treatment Market
13.4.1. Argentina Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. Argentina Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
13.4.3. Argentina Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.5. Rest of Latin America Global Liver Cirrhosis Treatment Market
13.5.1. Rest of Latin America Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Rest of Latin America Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
13.5.3. Rest of Latin America Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14. MEA Global Liver Cirrhosis Treatment Market
14.1. MEA Global Liver Cirrhosis Treatment Market
14.1.1. MEA Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. MEA Liver Cirrhosis Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. MEA Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
14.1.4. MEA Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.2. GCC Global Liver Cirrhosis Treatment Market
14.2.1. GCC Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. GCC Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
14.2.3. GCC Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.3. South Africa Global Liver Cirrhosis Treatment Market
14.3.1. South Africa Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. South Africa Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
14.3.3. South Africa Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.4. Rest of MEA Global Liver Cirrhosis Treatment Market
14.4.1. Rest of MEA Liver Cirrhosis Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Rest of MEA Liver Cirrhosis Treatment Market Size and Forecast, By Treatment Type, 2023-2034 (Revenue USD Bn)
14.4.3. Rest of MEA Liver Cirrhosis Treatment Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15. Competitor Analysis
15.1. Company Market Share Analysis, 2023
15.2. Major Recent Developments
16. Company Profiles
16.1. Gilead Sciences, Inc.
16.2. AbbVie Inc.
16.3. Bristol-Myers Squibb Company
16.4. GlaxoSmithKline plc
16.5. Johnson & Johnson (Janssen Pharmaceuticals)
16.6. Merck & Co., Inc.
16.7. Novartis AG
16.8. Pfizer Inc.
16.9. Sanofi S.A.
16.10. Roche Holding AG
16.11. Allergan plc
16.12. Intercept Pharmaceuticals, Inc.
16.13. Shionogi & Co., Ltd.
16.14. AstraZeneca plc
16.15. Lilly (Eli Lilly and Company)
17. Conclusion18. Recommendations

Companies Mentioned

  • Gilead Sciences Inc.. AbbVie Inc.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Roche Holding AG
  • Allergan plc
  • Intercept Pharmaceuticals Inc.
  • Shionogi & Co. Ltd.
  • AstraZeneca plc
  • Lilly

Table Information